BioCentury | Jun 13, 2019
Emerging Company Profile

Gracell: Speeding up CAR T cells

...NA Number of employees: 90 Funds raised: About $100 million Investors: Temasek, Lilly Asia Ventures, Kington Capital...
BioCentury | Mar 2, 2019
Company News

Emerging company roundup: Anthos, Maze, Oyster Point

...$85 million B round for Gracell Biotechnologies Co. Ltd. (Suzhou, China) Monday. Lilly Asia Ventures, Kington Capital...
BioCentury | Feb 28, 2019
Financial News

Gracell raises $85M series B to advance cell therapies

...therapy company Gracell Biotechnologies Co. Ltd. (Suzhou, China) that closed Feb. 25. Lilly Asia Ventures, Kington Capital...
BioCentury | Feb 25, 2019
Financial News

Gracell raises $85M series B to advance cell therapies

...B round for cell therapy company Gracell Biotechnologies Co. Ltd. (Suzhou, China). Lilly Asia Ventures, Kington Capital...
BioCentury | Aug 31, 2018
Financial News

Harbin Gloria selling stake in biotech unit to new investors

...investors. The investors, which also include Suzhou Tonghe Phase II Venture Capital Partnership and Suzhou Kington Capital...
BioCentury | Aug 17, 2018
Financial News

Harbin Gloria selling stake in biotech unit

...investors. The investors, which also include Suzhou Tonghe Phase II Venture Capital Partnership and Suzhou Kington Capital...
Items per page:
1 - 6 of 6
BioCentury | Jun 13, 2019
Emerging Company Profile

Gracell: Speeding up CAR T cells

...NA Number of employees: 90 Funds raised: About $100 million Investors: Temasek, Lilly Asia Ventures, Kington Capital...
BioCentury | Mar 2, 2019
Company News

Emerging company roundup: Anthos, Maze, Oyster Point

...$85 million B round for Gracell Biotechnologies Co. Ltd. (Suzhou, China) Monday. Lilly Asia Ventures, Kington Capital...
BioCentury | Feb 28, 2019
Financial News

Gracell raises $85M series B to advance cell therapies

...therapy company Gracell Biotechnologies Co. Ltd. (Suzhou, China) that closed Feb. 25. Lilly Asia Ventures, Kington Capital...
BioCentury | Feb 25, 2019
Financial News

Gracell raises $85M series B to advance cell therapies

...B round for cell therapy company Gracell Biotechnologies Co. Ltd. (Suzhou, China). Lilly Asia Ventures, Kington Capital...
BioCentury | Aug 31, 2018
Financial News

Harbin Gloria selling stake in biotech unit to new investors

...investors. The investors, which also include Suzhou Tonghe Phase II Venture Capital Partnership and Suzhou Kington Capital...
BioCentury | Aug 17, 2018
Financial News

Harbin Gloria selling stake in biotech unit

...investors. The investors, which also include Suzhou Tonghe Phase II Venture Capital Partnership and Suzhou Kington Capital...
Items per page:
1 - 6 of 6